Sep 23, 2026 04:06PM
Aug 11, 2026 04:16PM
Jun 14, 2026 02:01PM
Jun 1, 2026 01:46PM
Jun 1, 2026 06:59AM
May 6, 2026 04:41PM
Apr 27, 2026 05:29AM TD Cowen Starts Mineralys Therapeutics, Inc. (MLYS) at Buy
Mar 13, 2026 12:40PM
Mar 13, 2026 07:59AM
Mar 13, 2026 07:33AM
Mar 12, 2026 04:14PM
Mar 10, 2026 09:32AM
Mar 10, 2026 06:12AM
Dec 19, 2025 07:40AM Mineralys Therapeutics (MLYS) PT Raised to $52 at Stifel on Lorundrostat Potential
Nov 10, 2025 04:20PM
Nov 6, 2025 02:26PM
Sep 8, 2025 07:13AM
Sep 3, 2025 05:33AM
Aug 18, 2025 02:08PM
Aug 12, 2025 04:09PM
Jul 14, 2025 08:20AM Jefferies Reiterates Hold Rating on Mineralys Therapeutics, Inc. (MLYS)
Jun 30, 2025 11:19AM
Jun 18, 2025 06:44AM
Jun 17, 2025 07:00AM
Jun 10, 2025 04:15PM
May 20, 2025 08:01AM
May 12, 2025 04:28PM
Apr 23, 2025 05:25PM Mineralys Therapeutics (MLYS) announces publication of phase 2 Advance-HTN results
Mar 31, 2025 08:18AM
Mar 17, 2025 08:00AM
Mar 11, 2025 10:20PM
Mar 10, 2025 04:03PM
Mar 10, 2025 04:01PM
Mar 10, 2025 10:40AM
Mar 10, 2025 07:01AM Mineralys Therapeutics (MLYS) Announces Positive Topline Results from Launch-HTN and Advance-HTN Trials of Lorundrostat
Mar 7, 2025 04:01PM
Feb 25, 2025 09:40AM
Feb 12, 2025 07:04AM
Feb 4, 2025 08:06AM
Jan 8, 2025 08:06AM
Nov 11, 2024 04:06PM
Aug 14, 2024 05:52AM Goldman Sachs Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
Aug 14, 2024 05:23AM
Aug 13, 2024 04:07PM
Jul 10, 2024 06:18AM
Jun 14, 2024 08:01AM

467,448 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All